NCT04238819 2026-03-02
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Phase 1/2 Completed
Clinical Trials
5 trialsNCT01837862 2024-07-05
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Northwell Health
Phase 1/2 Completed
NCT00003616 2018-06-27
Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT02848794 2017-06-16
Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
The First People's Hospital of Lianyungang
Phase 1/2 Unknown
NCT00283556 2010-01-20
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
Kentuckiana Cancer Institute
Phase 1/2 Completed